参考文献/References:
[1] 杜丽坤,李佳睿,刘春燕,等.调补肝肾法治疗绝经后骨质疏松症[J].辽宁中医杂志,2022,49(3):217-220.
[2] 乌力吉巴特尔.蒙医人体体质学浅谈[J].中国中医基础医学杂志,2002,8(4):241-242.
[3] MEHTA S,YILDIRIM G,LIU Z,et al.SAT-176 cellular mechanisms of impaired bone remodeling in type 1 diabetes mellitus[J].Journal of the Endocrine Society,2019,3(Supplement1):215-219.
[4] 刘石平,廖二元,伍汉文,等.绝经后骨质疏松大鼠模型的综合评价[J].湖南医科大学学报,2001,26(2):111-114.
[5] 印丹丹,封瑞,任丽菲,等.阴道涂片法鉴定大鼠生理周期的应用评价[J].解剖科学进展,2014,20(4):360-363.
[6] 孙敬方.动物实验方法学[M].北京:人民卫生出版社,2001:423.
[7] SIMS N A,MARTIN T J.Coupling the activities of bone formation and resorption:A multitude of signals within the basic multicellular unit[J].Bone Key Reports,2014,8(3):481.
[8] FAUGERE M C,OKAMOTO S,DELUCA H F,et al.Calcitriol corrects bone loss induced by oophorectomy in rats[J].The American Journal of Physiology,1986,250(1 Pt 1):35-38.
[9] VASIKARAN S D,CHUBB S A.The use of biochemical markers of bone turnover in the clinical management of primary and secondary osteoporosis[J].Endocrine,2016,52(2):222-225.
[10] 占允中,叶舟,占蓓蕾,等.绝经后骨质疏松性腰椎骨折患者血清β-CTx、PINP水平及意义[J].中国现代医生,2018,56(20):9-12.
[11] 丁瑞,阳毅,侯俊霞,等.骨形成指标PINP与骨吸收指标β-CTX 在2型糖尿病合并骨质疏松中作用的研究[J].中国骨质疏松杂志,2017,23(3):318-321.
[12] 赵玺.绝经妇女骨关节炎及骨质疏松症的相关性研究[D].遵义:遵义医学院,2014.
[13] WANBY P,NOBIN R,VON S P,et al.Serum levels of the bone turnover markers dickkopf-1,sclerostin,osteoprotegerin,osteopontin,osteocalcin and 25-hydroxyvitamin D in Swedish geriatric patients aged 75 years or older with a fresh hip fracture and in healthy controls[J].Journal of Endocrinological Investigation,2016,39(8):855-863.
[14] 张萌萌,张秀珍,邓伟民,等.骨代谢生化指标临床应用专家共识(2019)[J].中国骨质疏松杂志,2019,25(10):1357-1372.
[15] CROFTON P M,EVANS N,STEPHEN R.Serum crosslaps compared with other markers of bone turnover in severely malnourished children before and after refeeding[J].Clinical Chemistry,2003,49(1):192-195.
[16] 刘敏杰.绝经后骨质疏松患者血清 CTRP9、PINP、β-CTX 与骨密度相关性分析[J].中国医学创新,2021,18(20):173-176.
[17] 赵和平.P1NP、β-Crosslaps与绝经老年女性骨质疏松相关性研究[J].陕西医学杂志,2014,43(7):865-866.
[18] FANG H,ZHANG H,WANG Z,et al.Systemic immune-inflammation index acts as a novel diagnostic biomarker for postmenopausal osteoporosis and could predict therisk of osteoporotic fracture[J].Journal of Clinical Laboratory Analysis,2020,34(1):e23016.
[19] MEHTA S,YILDIRIM G,LIU Z,et al.SAT-176 cellular mechanisms of impaired bone remodeling in type 1 diabetes mellitus[J].Journal of the Endocrine Society,2019,3(Supplement1):11119.
[20] KANIS J A,COOPER C,RIZZOLI R,et al.Mangement of osteoporosis in postmenopausal women[J].Osteoporos Int,2019,30(1):3-44.
[21] CHEN B,LI H Z.Association of IL-6 174G/C(rs1800795)and 572C/G(rs1800796)polymorphisms with risk of osteoporosis:A meta-analysis[J].BMC Musculoskelet Disord,2020,21(1):330.
[22] MUNDY G R.Osteoporosis and inflammation[J].Nutrition reviews,2007,65(12Pt2):S147-S151.
[23] DE MARTINIS M,GINALDI L,SIRUFO M M,et al.Alarmins in osteoporosis,RAGE,IL-1,and IL-33 pathways:A literature review[J].Medicina(Kaunas),2020,56(3):138.
[24] 袁显群.痛风性关节炎伴骨质疏松患者血清瘦素和骨保护素与炎性因子的关系[J].中国卫生工程学,2018,17(5):779-780.
[25] 高小明,关利君.蒙药蓝刺头对去卵巢大鼠血清碱性磷酸酶及白细胞介素-1的影响[J].中华中医药学刊,2016,34(12):2924-2926.
相似文献/References:
[1]陈巨鹏,严晓莺,黄国淳△,等.从燮理肝脾肾治疗绝经后骨质疏松症探讨*[J].陕西中医,2020,(11):1635.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.031]
CHEN Jupeng,YAN Xiaoying,HUANG Guochun,et al.Treatment of postmenopausal osteoporosis by regulating liver,spleen and kidney[J].,2020,(1):1635.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.031]
[2]周大标,吴冰心,阳 越,等.基于肝脾肾探讨绝经后骨质疏松症治疗机制[J].陕西中医,2022,(6):752.[doi:DOI:10.3969/j.issn.1000-7369.2022.06.018]
ZHOU Dabiao,WU Bingxin,YANG Yue,et al.Mechanism of postmenopausal osteoporosis treatment based on liver spleen and kidney[J].,2022,(1):752.[doi:DOI:10.3969/j.issn.1000-7369.2022.06.018]
[3]岳建彪,苟 静,魏翾娣,等.中医综合疗法联合运动干预治疗老年绝经后骨质疏松症临床研究[J].陕西中医,2022,(10):1380.[doi:DOI:10.3969/j.issn.1000-7369.2022.10.013]
YUE Jianbiao,GOU Jing,WEI Xuandi,et al.Clinical study on traditional Chinese medicine comprehensive therapy combined with exercise intervention in the treatment of elderly postmenopausal osteoporosis[J].,2022,(1):1380.[doi:DOI:10.3969/j.issn.1000-7369.2022.10.013]
[4]廖 敏,谭 洁,吉 滔,等.补肾健骨汤对绝经后骨质疏松症患者骨代谢指标及性激素水平影响研究[J].陕西中医,2023,(6):726.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.009]
LIAO Min,TAN Jie,JI Tao,et al.Effect of Bushen Jiangu decoction on bone metabolic indexes and sex hormone levels in postmenopausal osteoporosis patients[J].,2023,(1):726.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.009]
[5]屈佳乐,李 刚,刘 江.艾灸防治绝经后骨质疏松症研究进展[J].陕西中医,2023,(7):983.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.037]
[6]鲁志林,陈继东,周广文,等.名中医向楠补肾化痰方治疗绝经后骨质疏松症经验[J].陕西中医,2024,(5):687.[doi:DOI:10.3969/j.issn.1000-7369.2024.05.026]
LU Zhilin,CHEN Jidong,ZHOU Guangwen,et al.Professor XIANG Nan's experience in treating postmenopausal osteoporosis with Bushen Huatan prescription[J].,2024,(1):687.[doi:DOI:10.3969/j.issn.1000-7369.2024.05.026]